Enhanced detection of circulating tumor DNA by fragment size analysis
Authors:
- Florent MouliereFMFlorent Mouliere
- Dineika ChandranandaDCDineika Chandrananda
- Anna M. PiskorzAPAnna M. Piskorz
- Elizabeth K. MooreEMElizabeth K. Moore
- Teodora GoranovaTGTeodora Goranova
- Francesco MarassFMFrancesco Marass
- Katrin HeiderKHKatrin Heider
- Jonathan C. M. WanJWJonathan C. M. Wan
- Anna SupernatASAnna Supernat
Top Cited Papers
- 7 November 2018
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (466)
Abstract
Selective sequencing or in silico analysis for differences in DNA fragment size can improve the detection of circulating tumor DNA.Keywords
Funding Information
- H2020 European Research Council (337905)
This publication has 49 references indexed in Scilit:
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNAScience Translational Medicine, 2012
- High Fragmentation Characterizes Tumour-Derived Circulating DNAPLOS ONE, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the FetusScience Translational Medicine, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in SerumJournal of Clinical Oncology, 2006
- Cell-Free DNA in Human Blood PlasmaPancreas, 1998